Wearable technology has progressed significantly, such that today's smartwatches are able to offer advanced health monitoring functions, including the electrocardiogram (ECG). This study presents a dataset that can be used to clinically assess the accuracy of four leading smartwatch models: Apple Watch Series 9, Samsung Galaxy Watch 6, Fitbit Sense 2, and Withings ScanWatch. Using the standardized protocol of the International Electrotechnical Commission (IEC 60601-2-25:2011) and a METRON PS-440 patient simulator, controlled ECG signals were generated and recorded to assess smartwatch performance against a reference electrocardiograph (Philips TC30). Parameters such as heart rate (30 to 300 beats per minute), R-wave amplitude (500 to 2000 µV), and ST-segment elevation/depression (-800 to +800 µV) were configured in the patient simulator and recorded five times across all devices, resulting in a total of 900 records in the dataset. This extensive dataset provides valuable information on the feasibility of smartwatches as diagnostic tools, allowing for the observation of both their strengths and limitations for clinical and remote cardiovascular monitoring.
The recordings from the smartwatches last 30 seconds and correspond to Lead I, with a different sampling rate for each device: 512 Hz for Apple Watch Series 9; 500 Hz for Samsung Galaxy Watch 6; 250 Hz for Fitbit Sense 2; and 300 Hz for Withings ScanWatch. In the case of the Philips TC30 reference device, the recordings last 11 seconds, include 12 leads and have a sampling rate of 500 Hz.